HomeStock ScreenerHindustan Bio Sciences

Hindustan Bio Sciences Share Price | Hindustan Bio Sciences Stock Screener

HINDBIO Software Products
Share Price BSE
₹7.11
▼ -0.36 (-4.82%)
2026-07-20 00:00:00
As of July 20, 2026, the Hindustan Bio Sciences share price (BSE: HINDBIO) is ₹7.11, down 4.82% from the previous close, with shares trading between ₹7.10 and ₹7.44, and a 52-week range of ₹5.04–₹9.66. Analyse HINDBIO share price charts and track historical price performance. Use the Hindustan Bio Sciences stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Hindustan Bio Sciences Market Cap ₹7.44 Cr.
HINDBIO P/E Ratio (TTM) -90.00
Hindustan Bio Sciences P/B Ratio 8.89
EPS (TTM) ₹-0.08
Dividend Yield -
Debt to Equity 2.98
HINDBIO 52 Week High ₹9.66
Hindustan Bio Sciences 52 Week Low ₹5.04
Operating Margin -8.00%
Profit Margin -
HINDBIO Revenue (TTM) ₹1.00
EBITDA -
Net Income -
Total Assets ₹3.00
Total Equity ₹1.00

Hindustan Bio Sciences Share Price Chart

Screen Hindustan Bio Sciences share price with an interactive chart. Analyse HINDBIO price trends and volatility across different timeframes.

Hindustan Bio Sciences Company Profile - Fundamental Screener

Screen Hindustan Bio Sciences company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for HINDBIO shares.
Sector Information Technology
Industry Software Products
Sub-Sector Software Products
Segment E
ISIN INE597C01021

Hindustan Bio Sciences Balance Sheet Screener

Screen HINDBIO balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017
Assets
Total Assets 3 3 3 3 3 4 6 6 4 6
Current Assets 1 1 1 1 1 1 2 2 0 1
Fixed Assets 0 0 0 0 0 0 0 0 0 0
Liabilities
Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 2 3 3 1 1 1 2 3 1 1
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0
Shareholders' Equity
Total Equity 1 1 1 1 1 1 2 2 2 4
Share Capital 2 2 2 2 10 10 10 10 10 10
Reserves & Surplus -1 -1 -1 -1 -10 -9 -8 -8 -8 -6

Hindustan Bio Sciences Income Statement Screener - Profit & Revenue Analysis

Screen Hindustan Bio Sciences income statement and profit fundamentals. Analyze HINDBIO quarterly results, revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Hindustan Bio Sciences share price evaluation.
Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March 2015-March
Revenue 1 1 1 1 0 1 2 4 1 1 1 1
Expenses 1 1 1 1 1 2 2 3 3 2 1 2
EBITDA 0 0 0 0 -1 -1 0 0 -2 -1 0 -1
Operating Profit % -8.00% 12.00% 6.00% -3.00% -118.00% -91.00% 7.00% 4.00% -228.00% -46.00% -10.00% -163.00%
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 0 0 0 0 -1 -1 0 0 -2 -1 -2 -1
Tax 0 0 0 0 0 0 0 0 0 0 0 0
Net Profit 0 0 0 0 -1 -1 0 0 -2 -1 -2 -2
EPS -0.08 0.10 0.06 -0.04 -0.50 -0.92 0.08 0.11 -2.22 -0.48 -2.04 -1.42

Hindustan Bio Sciences Cash Flow Screener - Liquidity Fundamentals

Screen HINDBIO cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March
Operating Activities 0 -1 0 0 1 1 -1 0 0 1
Investing Activities 0 0 0 0 0 0 0 0 0 0
Financing Activities 0 1 0 0 -1 -1 2 0 0 -1
Net Cash Flow 0 0 0 0 0 0 0 0 0 0

Hindustan Bio Sciences Shareholding Pattern Screener

See Hindustan Bio Sciences shareholding pattern with promoter, FII, and DII holdings. Check Hindustan Bio Sciences promoter holding and ownership changes for HINDBIO on TickJournal.
Item 2026-Mar 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept
Promoter Holding 12.19% 12.19% 12.19% 12.19% 12.19% 12.19% 12.19% 12.19%
FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 81.48% 84.02% 84.02% 81.68% 81.69% 84.00% 84.06% 84.08%
Other Holding 6.33% 3.79% 3.79% 6.13% 6.12% 3.81% 3.75% 3.73%
Shareholder Count 11,530 11,246 11,620 11,405 11,516 10,921 11,779 11,618

Hindustan Bio Sciences Share Dividend Screener - Share Yield Analysis

Check Hindustan Bio Sciences dividend history with payout and yield data. View Hindustan Bio Sciences dividend details including ex-dates and amounts for HINDBIO stock.
No dividends declared by Hindustan Bio Sciences.

Hindustan Bio Sciences Stock Index Membership

See which indices include Hindustan Bio Sciences stock. Check HINDBIO index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Hindustan Bio Sciences is not part of any tracked indices.
Only major market indices are tracked in our system.

Hindustan Bio Sciences Market Events Screener - Corporate Actions

Get Hindustan Bio Sciences corporate actions including splits, bonuses, and buybacks. Check Hindustan Bio Sciences stock events that may affect HINDBIO share price.
Announcement Date Record Date Event Type Information Price Impact
2026-05-30 2026-05-30 Quarterly Result Announcement NA -3.41%
2026-01-31 2026-01-31 Quarterly Result Announcement NA 8.51%
2025-10-31 2025-10-31 Quarterly Result Announcement NA -15.90%
2025-09-30 2025-09-30 Annual General Meeting NA -9.55%
2025-07-31 2025-07-31 Quarterly Result Announcement NA -1.44%
2025-05-30 2025-05-30 Quarterly Result Announcement NA 34.73%
2025-01-30 2025-01-30 Quarterly Result Announcement NA -5.76%
2024-10-30 2024-10-30 Quarterly Result Announcement NA 7.85%
2024-09-30 2024-09-30 Annual General Meeting NA 14.68%
2023-12-29 2023-12-29 Extraordinary General Meeting NA -3.07%

Hindustan Bio Sciences Competitors Screener - Peer Comparison

Screen HINDBIO competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Oracle Financial Services Software 102,266 38.45 7,943 11.07% 2,639 75.65
Tanla Platforms 7,553 14.34 4,455 9.52% 509 65.54
CE Info Systems 6,489 44.28 474 -8.07% 117 79.56
Moschip Technologies 4,522 130.77 585 24.29% 33 61.55
Ramco Systems 3,331 71.99 701 17.43% 42 73.75
TechNVision Ventures 2,184 10588.20 269 17.46% 0 11.94
Nucleus Software 2,036 16.99 940 4.64% 117 53.50
Blue Cloud Softech Solutions 1,999 31.29 1,002 25.60% 61 55.95
Unicommerce eSolutions 991 48.69 204 45.75% 19 48.79
Quick Heal Technologies 912 -83.38 261 -13.08% -21 41.32

Hindustan Bio Sciences Company Announcements - News Screener

Screen HINDBIO latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
2026-07-17 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-06-27 Closure of Trading Window -
2026-06-02 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-05-30 Appointment Of Internal Auditor For The Year 2026-27 -
2026-05-30 Audited Financial Results For The Fourth Quarter And Financial Year Ended 31St March 2026 -
2026-05-30 Board Meeting Outcome for Approved Audited Results For The Fourth Quarter And Financial Year Ended 2026 -
2026-05-21 Compliances-Reg.24(A)-Annual Secretarial Compliance -
2026-05-19 Board Meeting Intimation for Board Meeting Intimation For The Quarter And Year Ended On 31St March 2026 -
2026-04-14 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-03-25 Closure of Trading Window -
2026-02-02 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-01-31 Un-Audited Results For Quarter Ended 31-12-2025 -
2026-01-31 Board Meeting Outcome for Outcome Of Board Meeting -
2026-01-24 Revised Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 -
2026-01-23 Announcement under Regulation 30 (LODR)-Acquisition -
2026-01-22 Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 -
2026-01-19 Board Meeting Intimation for Un-Audited Financial Results Of The Company For The Quarter Ended 31.12.2025 -
2026-01-13 Special Window For Re-Lodgment Of Transfer Requests Of Physical Shares Pursuant To SEBI Circular Dated July 2 2025 -
2026-01-08 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2025-12-26 Closure of Trading Window -